Advances in organ preservation techniques and future prospects

A review article published in Engineering delves into the crucial field of organ preservation, exploring its history, current techniques, and future prospects.

Gilead’s oncology campaign spotlights metastatic breast cancer patients who often feel unseen

Gilead Sciences is focusing on the overlooked needs of people living with metastatic and triple-negative breast cancer in its latest unbranded oncology campaign. The “Expose

March 9, 2024

Cemdisiran by Alnylam Pharmaceuticals for Myasthenia Gravis: Likelihood of Approval

Cemdisiran is under clinical development by Alnylam Pharmaceuticals and currently in Phase III for Myasthenia Gravis.

February 9, 2024

Evotec slashes workforce by 400 people in “difficult market” – Pharmaceutical Technology

Evotec is cutting 400 jobs as part of a priority reset for sustainable profitable growth. Credit: Dragon Claws via Shutterstock. German life science company Evotec

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.